09.05.2017 12:10

NLS Pharma attracts new investors

NLS Pharma, a Swiss-based biotech group focussing on treatments for attention deficit hyperactivity disorder and other neurological disorders, has completed a Series B founding round. The company has as well completed a Phase 2 study of its lead compound.

09.05.2017 09:01

Swiss Post invests in start-ups

Swiss Post launches a corporate venturing initiative. The corporation plans to invest increasingly in start-ups relevant to its operations. To this end, it recently entered into a cooperation with

09.05.2017 08:02

BC Platforms Closes USD $10 million Series B Financing

BC Platforms is a big data company developing a platform with clinical and genomic data from 5 million subjects. The company headquartered in Basel announced that it has closed a US10 million financing round. , to transform drug development and bring clinical benefits to patients.


04.05.2017 09:50

DBS System attracts Swiss pension fund as an investor

Medtech startup DBS System has closed a CHF2.5million Series A financing round. The investment of the new shareholder was led by investiere with CHF700k coming from the Swiss pension fund Nest. With this investment, DBS System will industrialize its second generation HemaXis blood collection device.


03.05.2017 14:31

Zukunftsfonds Schweiz in Bern den Pensionskassen vorgestellt

Vertreter der Stiftung Pro Zukunftsfonds Schweiz präsentierten am 2. Mai vor rund 120 Verantwortlichen von Vorsorgeeinrichtungen das Projekt Zukunftsfonds Schweiz. Dieser Dachfonds soll im Sinne der Motion Graber geschaffen werden, damit Schweizer Pensionskassen vermehrt in wachstumsstarke Schweizer Jungunternehmen investieren.


02.05.2017 17:04

Crowdlending Pionier schliesst Finanzierungsrunde ab

Der Zuger Crowdlending Pionier Cashare hat die dritte Finanzierungsrunde abgeschlossen. Zudem unterstützen neu ein ausgewiesener Finanzrechts-Experte und eine Person mit grosser Erfahrung im Börsenwesen und Aufbau von innovativen Handelsplattformen das Unternehmen.


28.04.2017 14:14

HBM invests EUR 20 million in Amicus

HBM Healthcare Investments announced the closing of a new equity investment of EUR 20 million in two tranches into the privately held and Switzerland based Amicus SA. The financing will allow Amicus to accelerate the growth of its pharmaceutical business in Central and Eastern Europe (CEE).

Show All


13 Jun 2017, 9am - 5pm

Swiss Medtech Day 2017 Kursaal Bern, Kornhausstrasse 3, 3000 Bern

Show All


22.06.2017 08:30 - 18:30

Venture Capital Deal Camp IMD, Lausanne

Top viewed

Show All





Early summer heat